Main menu

Oxford Nanopore supports COVID-19 pandemic: epidemiology and research


Oxford Nanopore is working with public health laboratories around the world, and researchers in related areas, to support the current COVID-19 pandemic.  This includes rapid sequencing of the novel coronavirus SARS-CoV-2 – the virus that causes COVID-19, as well as approaches that characterise a broader range of pathogens in a sample.

A large number of scientists, from large centralised labs to smaller decentralised ones, are using nanopore sequencing to support rapid sharing of SARS-CoV-2 sequence data.  Rapid data sharing has been key to the public health response, and researchers all over the world have been fast to share the genomes they have sequenced on public databases such as GISAID, GenBank or elsewhere.

As numbers of cases increased, laboratories have built capacity to sequence larger numbers of the genomes, typically progressing from using the MinION device to the GridION device for sequencing. Thousands of genomes sequenced using nanopore technology are now available in public databases.

Due to the extensive amount of work in this area, we have created a COVID-19 mini-site, that includes: extensive research and epidemiology performed by researchers in the nanopore community and guidance on how to use nanopore sequencing

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag